Market analytics and operational performance indicators
Rocket Lab SEC Filings
Browse Rocket Lab filings, review key metrics, and open source documents from one place.
SEC Command Deck
Use this feed to separate quarterly and annual operating disclosures from one-off event filings and insider ownership changes before opening full analysis or source documents.
What matters now
Latest Filings
Read the brief first, then open the full filing only when you need document-level detail.
Rocket Lab's subsidiary SolAero entered a Direct Funding Agreement with U.S. Department of Commerce for up to $23.9M under CHIPS Act to expand compound semiconductor manufacturing in Albuquerque, NM. Rocket Lab guarantees obligations and commits $32M equity contribution. Funds disbursed via milestones with operational restrictions.
Arjun Kampani, General Counsel of Rocket Lab USA, sold 28,562 shares on 11/25/2024 at a weighted average price of $24.1456 to cover tax obligations from vesting restricted stock units (RSUs). This was an automatic, non-discretionary transaction. The signal is neutral as it reflects routine tax withholding rather than voluntary selling.
Frank Klein, Chief Operations Officer of Rocket Lab USA, sold 35,968 shares on 11/25/2024 at a weighted average price of $24.1456 to cover tax obligations from vesting restricted stock units. This was an automatic, non-discretionary transaction. The signal is neutral as it is routine tax-related selling.
Chief Financial Officer Adam C. Spice sold 62,511 shares of Rocket Lab USA Inc. common stock on November 25, 2024, at a weighted average price of $24.1456. This was an automatic sell-to-cover transaction to satisfy tax withholding obligations upon RSU vesting, not a discretionary sale. The signal is neutral as it reflects routine compensation-related activity.
Director Merline Saintil sold 50,000 shares of Rocket Lab USA common stock on 11/26/2024 at $25.55 average price, totaling ~$1.28M. The discretionary transaction (no 10b5-1 plan) reduced her direct holdings from ~482K to 432K shares. This signals moderate bearish sentiment.
Rocket Lab director Merline A. Saintil filed Form 144 to sell 50,000 common shares acquired via 2022 RSU vesting. The proposed sale on 11/26/2024 has an aggregate market value of $1,277,475, with no prior sales in the past 3 months. This routine disclosure signals personal liquidity needs but affirms no undisclosed material adverse information.
Rocket Lab officer Arjun Kampani filed Form 144 on 11/25/2024 notifying proposed sales of 7,505 common shares (value $181K) on 11/25/2024 and 21,057 shares (value $508K) dated 08/23/2024. Sales cover tax obligations from 52,472 RSUs vesting on 11/22/2024. Routine insider transaction with no prior 3-month sales reported.
Form 144 filed by Rocket Lab officer Frank Klein discloses intent to sell 35,968 common shares on 11/25/2024, valued at $868,468.94. Shares originate from 81,250 RSUs vesting on 11/22/2024 as compensation. Sale covers tax obligations; no prior 3-month sales reported. Routine insider transaction for investors tracking activity.
This Form 144 discloses Rocket Lab USA Inc. officer Adam C. Spice's intent to sell 62,511 common shares on 11/25/2024. Shares originated from 114,845 restricted stock units vesting on 11/22/2024 as compensation, with the sale covering tax obligations. Investors should note this routine insider transaction amid no prior 3-month sales.
Rocket Lab USA Director Jon A. Olson sold 50,000 shares of common stock on November 19, 2024, at a weighted average price of $20.6863. This discretionary sale, not under a 10b5-1 plan, reduced his direct holdings to 432,275 shares. The transaction signals moderate bearish sentiment.
Secured $23.9M CHIPS Act funding for SolAero semiconductor expansion
Key Telemetry
- • SolAero signed $23.9M Direct Funding Agreement on 2024-11-22 with U.S. Dept of Commerce under CHIPS Act.
- • Funding for compound semiconductor expansion at Albuquerque facility, milestone disbursements.
GC Kampani sold 28,562 shares ($690K) via sell-to-cover for RSU tax withholding.
Key Telemetry
- • Sold 28,562 shares (4.7% of post-transaction direct holdings of 608,996 shares) for RSU tax withholding.
- • Automatic, non-discretionary sell-to-cover transaction.
COO Klein sold 35,968 shares ($868K) via sell-to-cover for RSU tax withholding.
Key Telemetry
- • Sold 35,968 shares (2.4% of post-transaction direct holdings of 1,464,032 shares).
- • Routine automatic sell-to-cover for RSU vesting taxes, non-discretionary.
CFO Spice sold 62,511 shares ($1.51M) for RSU tax withholding.
Key Telemetry
- • Sale of 62,511 shares (~5% of 1.26M direct holdings) for tax withholding on RSU vesting.
- • Routine automatic transaction, not discretionary.
Director Saintil sold 50,000 shares ($1.28M) open market.
Key Telemetry
- • Discretionary sale of 50,000 shares (~10.4% of holdings, $1.28M value)
- • No 10b5-1 plan indicated; open market execution
Director Merline Saintil to sell 50,000 RKLB shares worth $1.28M.
Key Telemetry
- • Director Merline A. Saintil to sell 50,000 common shares on 11/26/2024.
- • Aggregate market value: $1,277,475; shares outstanding: 499,911,078.
Officer Kampani files Form 144 to sell ~28.6K RKLB shares for RSU tax coverage.
Key Telemetry
- • Arjun Kampani (Officer) to sell 7,505 shares ($181,213) on 11/25/2024 via Morgan Stanley.
- • Lists additional 21,057 shares ($508,434) with 08/23/2024 date; total ~28,562 shares (~$690K).
Rocket Lab officer Frank Klein to sell 35,968 shares ($868K) to cover RSU vesting taxes.
Key Telemetry
- • Frank Klein (officer) to sell 35,968 common shares on 11/25/2024 via Morgan Stanley.
- • Sale value: $868,468.94; from 81,250 RSUs vesting 11/22/2024 as compensation.
Rocket Lab officer Adam Spice files to sell 62,511 shares worth $1.5M to cover RSU taxes.
Key Telemetry
- • Adam C. Spice, Rocket Lab officer, to sell 62,511 common shares on 11/25/2024.
- • Sale value: $1,509,365.60; shares outstanding: 503,928,615 (~0.012% of total).
Director Olson sold 50,000 shares ($1.03M) at $20.69.
Key Telemetry
- • Sold 50,000 shares (~10.4% of pre-sale holdings of 482,275 shares), retaining 432,275 shares.
- • Discretionary open-market sale (no 10b5-1 plan indicated).